Literature DB >> 31280358

Renal flare in class V lupus nephritis: increased risk in patients with tubulointerstitial lesions.

Oh Chan Kwon1,2, Yong Mee Cho3, Ji Seon Oh4, Seokchan Hong1, Chang-Keun Lee1, Bin Yoo1, Yong-Gil Kim5.   

Abstract

The objective of this study is to investigate the risk factors of renal flare in patients with membranous lupus nephritis (class V lupus nephritis). Biopsy-proven pure membranous lupus nephritis patients diagnosed between January 1997 and September 2017 were studied. We assessed and compared the clinical and pathological parameters between patients who experienced renal flare and those who did not. To identify risk factors of renal flare, multivariable Cox proportional hazard regression analysis was performed. Out of the 53 patients with pure membranous lupus nephritis, 17 patients (32.1%) experienced renal flare during a median follow-up of 121.5 months (range 44.4-196.9). Patients who experienced renal flare had significantly higher proportion of tubulointerstitial inflammation (76.5% vs. 36.1%, p = 0.006) and tubular atrophy/interstitial fibrosis (70.6% vs. 27.8%, p = 0.003) at baseline. In multivariable Cox proportional hazard regression analysis, the presence of tubulointerstitial inflammation [adjusted hazard ratio (HR) 5.532, 95% confidence interval (CI) 1.722-17.776, p = 0.004] and tubular atrophy/interstitial fibrosis (adjusted HR 4.328, 95% CI 1.450-12.916, p = 0.009) at baseline was significantly associated with increased risk of renal flare. The presence of tubulointerstitial inflammation and tubular atrophy/interstitial fibrosis is associated with increased risk of renal flare in patients with membranous lupus nephritis.

Entities:  

Keywords:  Flare; Interstitial fibrosis; Membranous lupus nephritis; Tubular atrophy; Tubulointerstitial inflammation

Mesh:

Year:  2019        PMID: 31280358     DOI: 10.1007/s00296-019-04369-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

Review 1.  Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.

Authors:  Feng Yu; Mark Haas; Richard Glassock; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

2.  Renal flare prediction and prognosis in lupus nephritis Hispanic patients.

Authors:  J M Mejía-Vilet; B M Córdova-Sánchez; J M Arreola-Guerra; L E Morales-Buenrostro; N O Uribe-Uribe; R Correa-Rotter
Journal:  Lupus       Date:  2015-09-24       Impact factor: 2.911

3.  Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.

Authors:  G G Illei; K Takada; D Parkin; H A Austin; M Crane; C H Yarboro; E M Vaughan; T Kuroiwa; C L Danning; J Pando; A D Steinberg; M F Gourley; J H Klippel; J E Balow; D T Boumpas
Journal:  Arthritis Rheum       Date:  2002-04

4.  Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring.

Authors:  Christine Hsieh; Anthony Chang; Daniel Brandt; Riteesha Guttikonda; Tammy O Utset; Marcus R Clark
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-06       Impact factor: 4.794

5.  Mortality in systemic lupus erythematosus.

Authors:  S Bernatsky; J-F Boivin; L Joseph; S Manzi; E Ginzler; D D Gladman; M Urowitz; P R Fortin; M Petri; S Barr; C Gordon; S-C Bae; D Isenberg; A Zoma; C Aranow; M-A Dooley; O Nived; G Sturfelt; K Steinsson; G Alarcón; J-L Senécal; M Zummer; J Hanly; S Ensworth; J Pope; S Edworthy; A Rahman; J Sibley; H El-Gabalawy; T McCarthy; Y St Pierre; A Clarke; R Ramsey-Goldman
Journal:  Arthritis Rheum       Date:  2006-08

Review 6.  Membranous Lupus Nephritis: The Same, But Different.

Authors:  Frank Ward; Joanne M Bargman
Journal:  Am J Kidney Dis       Date:  2016-09-20       Impact factor: 8.860

7.  Interstitial inflammation and long-term renal outcomes in lupus nephritis.

Authors:  A O Alsuwaida
Journal:  Lupus       Date:  2013-10-04       Impact factor: 2.911

Review 8.  Update on Lupus Nephritis.

Authors:  Salem Almaani; Alexa Meara; Brad H Rovin
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 8.237

9.  Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study.

Authors:  Nathalie Chavarot; David Verhelst; Agathe Pardon; Valérie Caudwell; Lucile Mercadal; Antoinette Sacchi; Catherine Leonardi; Véronique Le Guern; Alexandre Karras; Eric Daugas
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

10.  Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy.

Authors:  Woong Na; Kijong Yi; Young Soo Song; Moon Hyang Park
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.